Metraipolis › archive › dc_ce10fa63a7e6

Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42511891
DOI
10.3390/biomedicines14071416
License (as archived)
solo-consultazione
Archived
2026-10-19T05:18:13.958Z
SHA-256 of the archived text
a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015
Stable URL of this page
https://metraipolis.com/documento/dc_ce10fa63a7e6

How to cite

Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891 — Europe PMC (en), https://europepmc.org/article/MED/42511891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce10fa63a7e6 (Metraipolis archive dc_ce10fa63a7e6, sha256 a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015)
BibTeX
@misc{dcce10fa63a7e6,
  title = {Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series — Europe PMC PMID:42511891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42511891},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce10fa63a7e6; sha256 a9231eb99b828838e2a147c36403ba7e417c69e03cb3e1ca361d96a018bbb015},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42511891. Agents can read the archived copy with the MCP tool read_document.